Filing Details
- Accession Number:
- 0001104659-21-076998
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-04 16:06:09
- Reporting Period:
- 2021-06-02
- Accepted Time:
- 2021-06-04 16:06:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1824293 | Vallon Pharmaceuticals Inc. | VLON | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398278 | M. Leanne Kelly | C/O Vallon Pharmaceuticals, Inc. 100 N. 18Th Street, Suite 300 Philadelphia PA 19103 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-02 | 3,657 | $4.00 | 3,657 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 1,085 | $4.05 | 4,742 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-04 | 1,508 | $4.08 | 6,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
